• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合系统免疫炎症指数(SII)和预后营养指数(PNI)在实体瘤中的预后价值

The Prognostic Value of Combined Systemic Immune-Inflammatory Index (SII) and Prognostic Nutritional Index (PNI) in Solid Tumor.

作者信息

Zhang Yan, Tang Min, Gu Qian-Hui, Zhou Li-Na, Chen Min-Bin

机构信息

Department of Oncology & Radiotherapy, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu, 215300, People's Republic of China.

出版信息

Cancer Manag Res. 2025 Jul 8;17:1351-1359. doi: 10.2147/CMAR.S523419. eCollection 2025.

DOI:10.2147/CMAR.S523419
PMID:40656135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12255326/
Abstract

BACKGROUND

Inflammation and nutrition status were the essential factors for cancer initiation and progression. Previous studies have confirmed systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) could predict the prognosis of cancer patients. The aim of this study was to evaluate the pre-treatment SII and PNI in predicting outcomes in different cancers.

METHODS

The retrospective study included 508 cancer cases diagnosed between June 2013 and June 2022. The pre-treatment SII and PNI were calculated from peripheral blood samples, and the cutoff value was determined by receiver operating characteristic (ROC). The association of SII, PNI with clinicopathological characters and prognosis were assessed by Cox regression and Kaplan-Meier methods.

RESULTS

The ideal preoperative SII and PNI cutoff values were 792.0 and 49.825, respectively. High SII group as well as low PNI group had worse prognosis. Patients satisfied both high SII and low PNI had the lowest overall survival (OS) rate ( < 0.001). Multivariable Cox regression analysis identified that the tumor stage ( < 0.001), BMI ( = 0.042), SII ( = 0.001) and AGR ( = 0.047) were independently prognostic markers for OS.

CONCLUSION

High level of pretreatment SII may be an independent prognostic factor for cancer patients. Patients with both high SII and low PNI had the worst prognosis.

摘要

背景

炎症和营养状况是癌症发生和发展的重要因素。既往研究证实,全身免疫炎症指数(SII)和预后营养指数(PNI)可预测癌症患者的预后。本研究旨在评估治疗前SII和PNI对不同癌症患者预后的预测价值。

方法

本回顾性研究纳入了2013年6月至2022年6月期间诊断的508例癌症病例。根据外周血样本计算治疗前SII和PNI,并通过受试者工作特征曲线(ROC)确定临界值。采用Cox回归和Kaplan-Meier方法评估SII、PNI与临床病理特征及预后的相关性。

结果

术前理想的SII和PNI临界值分别为792.0和49.825。高SII组和低PNI组的预后较差。同时满足高SII和低PNI的患者总生存率(OS)最低(<0.001)。多变量Cox回归分析确定,肿瘤分期(<0.001)、BMI(=0.042)、SII(=0.001)和AGR(=0.047)是OS的独立预后标志物。

结论

治疗前高SII水平可能是癌症患者的独立预后因素。同时具有高SII和低PNI的患者预后最差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb03/12255326/002614c7fde6/CMAR-17-1351-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb03/12255326/f6205a0859dc/CMAR-17-1351-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb03/12255326/fae1f935d0c5/CMAR-17-1351-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb03/12255326/002614c7fde6/CMAR-17-1351-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb03/12255326/f6205a0859dc/CMAR-17-1351-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb03/12255326/fae1f935d0c5/CMAR-17-1351-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb03/12255326/002614c7fde6/CMAR-17-1351-g0003.jpg

相似文献

1
The Prognostic Value of Combined Systemic Immune-Inflammatory Index (SII) and Prognostic Nutritional Index (PNI) in Solid Tumor.联合系统免疫炎症指数(SII)和预后营养指数(PNI)在实体瘤中的预后价值
Cancer Manag Res. 2025 Jul 8;17:1351-1359. doi: 10.2147/CMAR.S523419. eCollection 2025.
2
Prognostic Value of the SII-PNI Score in Unresectable HCC Treated with Transcatheter Arterial Chemoembolization Combined with Lenvatinib and PD-1 Inhibitors.SII-PNI评分在经肝动脉化疗栓塞联合乐伐替尼及PD-1抑制剂治疗的不可切除肝癌中的预后价值
J Inflamm Res. 2025 Jun 10;18:7545-7557. doi: 10.2147/JIR.S520339. eCollection 2025.
3
Prognostic predictive value of the preoperative systemic immunoinflammatory index combined with the neutrophil-to-lymphocyte ratio in patients with primary liver cancer undergoing transarterial chemoembolization.术前全身免疫炎症指数联合中性粒细胞与淋巴细胞比值对接受经动脉化疗栓塞的原发性肝癌患者的预后预测价值
Oncol Lett. 2025 Jun 27;30(3):414. doi: 10.3892/ol.2025.15160. eCollection 2025 Sep.
4
Low prognostic nutritional index predicts poor outcome in newly diagnosed angioimmunoblastic T-cell lymphoma.低预后营养指数预示新诊断血管免疫母细胞性T细胞淋巴瘤预后不良。
Front Nutr. 2025 Jun 26;12:1622691. doi: 10.3389/fnut.2025.1622691. eCollection 2025.
5
Prognostic nutritional index as a potential predictor of prognosis in patients with sepsis: a retrospective cohort study.预后营养指数作为脓毒症患者预后的潜在预测指标:一项回顾性队列研究
Front Nutr. 2025 Jul 1;12:1600943. doi: 10.3389/fnut.2025.1600943. eCollection 2025.
6
Inflammatory markers including NLR, AFR and SII as prognostic factors in neuroblastoma.包括中性粒细胞与淋巴细胞比值(NLR)、天冬氨酸氨基转移酶与血小板比值(AFR)和全身免疫炎症指数(SII)在内的炎症标志物作为神经母细胞瘤的预后因素。
Sci Rep. 2025 Jul 6;15(1):24101. doi: 10.1038/s41598-025-10209-5.
7
Prognostic value of hemoglobin-to-red cell distribution width ratio and inflammation markers in colorectal cancer.血红蛋白与红细胞分布宽度比值及炎症标志物在结直肠癌中的预后价值
World J Gastrointest Oncol. 2025 Jun 15;17(6):106603. doi: 10.4251/wjgo.v17.i6.106603.
8
The Prognostic Value of the Systemic Immune-Inflammation Index in Glioblastoma Patients and the Establishment of a Nomogram.全身免疫炎症指数在胶质母细胞瘤患者中的预后价值及列线图的建立
Curr Med Sci. 2025 Apr 16. doi: 10.1007/s11596-025-00047-x.
9
Utility of Prognostic Nutritional Index and Systemic Immune-Inflammation Index Inpatients With Sudden Sensorineural Hearing Loss: A Large Prospective Cohort Study.预后营养指数和全身免疫炎症指数在突发性感音神经性听力损失患者中的应用:一项大型前瞻性队列研究
Immun Inflamm Dis. 2025 Jun;13(6):e70217. doi: 10.1002/iid3.70217.
10
Predictive value of preoperative inflammatory response markers on short-term postoperative complications following colorectal surgery: a secondary analysis of a randomized clinical trial.结直肠手术后术前炎症反应标志物对术后短期并发症的预测价值:一项随机临床试验的二次分析
Front Med (Lausanne). 2025 Jun 5;12:1536807. doi: 10.3389/fmed.2025.1536807. eCollection 2025.

本文引用的文献

1
The prognostic value of immune-nutritional status in metastatic colorectal cancer: Prognostic Nutritional Index (PNI).免疫-营养状态在转移性结直肠癌中的预后价值:预后营养指数(PNI)。
Support Care Cancer. 2024 May 23;32(6):374. doi: 10.1007/s00520-024-08572-6.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Systemic immune inflammation index and gastric cancer prognosis: A systematic review and meta‑analysis.
全身免疫炎症指数与胃癌预后:一项系统评价与荟萃分析。
Exp Ther Med. 2024 Feb 1;27(3):122. doi: 10.3892/etm.2024.12410. eCollection 2024 Mar.
4
Nomogram incorporating prognostic immune-inflammatory-nutritional score for survival prediction in pancreatic cancer: a retrospective study.列线图纳入预后免疫炎症营养评分用于胰腺癌生存预测:一项回顾性研究。
BMC Cancer. 2024 Feb 12;24(1):193. doi: 10.1186/s12885-024-11948-w.
5
Construction and validation of a prognostic nutritional index-based nomogram for predicting pathological complete response in breast cancer: a two-center study of 1,170 patients.基于预后营养指数的列线图预测乳腺癌病理完全缓解的构建与验证:一项对1170例患者的双中心研究
Front Immunol. 2024 Jan 11;14:1335546. doi: 10.3389/fimmu.2023.1335546. eCollection 2023.
6
Influence of Enteral Nutrition on Quality of Life in Head and Neck Cancer and Upper Gastrointestinal Tract Cancer Patients within a Pair-Matched Sample.肠内营养对配对样本中头颈部癌症和上消化道癌症患者生活质量的影响。
Nutrients. 2023 Nov 6;15(21):4698. doi: 10.3390/nu15214698.
7
Malnutrition in cancer patients: Causes, consequences and treatment options.癌症患者营养不良:原因、后果及治疗选择。
Eur J Surg Oncol. 2024 May;50(5):107074. doi: 10.1016/j.ejso.2023.107074. Epub 2023 Sep 14.
8
Prognostic value of nutritional and inflammatory markers in patients with hepatocellular carcinoma who receive immune checkpoint inhibitors.营养和炎症标志物在接受免疫检查点抑制剂治疗的肝细胞癌患者中的预后价值。
Oncol Lett. 2023 Aug 23;26(4):437. doi: 10.3892/ol.2023.14024. eCollection 2023 Oct.
9
Inflammation and malnutrition as markers of poor outcomes in head and neck cancer patients treated with nivolumab.免疫检查点抑制剂治疗头颈部癌患者中,炎症和营养不良作为不良预后的标志物。
Acta Otolaryngol. 2023 Aug;143(8):714-720. doi: 10.1080/00016489.2023.2240372. Epub 2023 Aug 3.
10
Clinical application of common inflammatory and nutritional indicators before treatment in prognosis evaluation of non-small cell lung cancer: a retrospective real-world study.常见炎症和营养指标在非小细胞肺癌治疗前预后评估中的临床应用:一项回顾性真实世界研究
Front Med (Lausanne). 2023 Jul 13;10:1183886. doi: 10.3389/fmed.2023.1183886. eCollection 2023.